CFDE Data Portal | Search MIR9-3HG

	Label	Description
	MIR9-3HG Gene (Entity type)	ENSG00000255571 - MIR9-3 host gene
	GSE240439 decitabine 1 v 2 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE238213 dopamine 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE195663 cisplatin 0 v 1 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE153867 olaparib 6 v 4 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 7 v 3 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE202434 GSE202438 talazoparib 10 v 5 human up Gene Set (Entity type)	A Gene Set from LINCS
	GSE239844 crizotinib 8 v 10 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE189035 inositol 2 v 7 human dn Gene Set (Entity type)	A Gene Set from LINCS
	GSE217776 GSE217829 MLL SGF29 CSNK2A1 knockout U-937 1 v 0 human dn Gene Set (Entity type)	A Gene Set from LINCS

MIR9-3HG

ENSG00000255571 - MIR9-3 host gene

GSE240439 decitabine 1 v 2 human up

A Gene Set from LINCS

GSE238213 dopamine 1 v 0 human dn

A Gene Set from LINCS

GSE195663 cisplatin 0 v 1 human up

A Gene Set from LINCS

GSE153867 olaparib 6 v 4 human dn

A Gene Set from LINCS

GSE97616 GSE97617 NOK overexpression HEK RNA Small Interfering 7 v 3 human dn

A Gene Set from LINCS

GSE202434 GSE202438 talazoparib 10 v 5 human up

A Gene Set from LINCS

GSE239844 crizotinib 8 v 10 human dn

A Gene Set from LINCS

GSE189035 inositol 2 v 7 human dn

A Gene Set from LINCS

GSE217776 GSE217829 MLL SGF29 CSNK2A1 knockout U-937 1 v 0 human dn

A Gene Set from LINCS

DISPLAY PER PAGE

@CFDE Workbench 2026

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2026

This repository is under review for potential modification in compliance with Administration directives.